GS
ENZY

Gagnon Securities’s Enzymotec Ltd ENZY Stock Holding History

Gagnon Securities’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-377,302
Closed -$234K – 98
2017
Q1 		$234K Hold
377,302
– – 0.1% 82
2016
Q4 		$194K Buy
377,302
+138,675
+58% +$913K 0.08% 83
2016
Q3 		$1.67M Sell
238,627
-3,243
-1% -$26K 0.71% 28
2016
Q2 		$2.02M Buy
+241,870
New +$2M 0.94% 23

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return

Gagnon Securities's ENZY Position: Q2 2017 in Review

Gagnon Securities sold out of Enzymotec Ltd (ENZY) in Q2 2017, closing a stake of 377,302 shares — an estimated $234K sold.

Gagnon Securities first reported a position in ENZY in Q2 2016 and held it in 4 quarters. The position peaked at $2.02M in Q2 2016. 21 funds tracked by Wall St. Rank hold ENZY as of Q2 2017.

  • Gagnon Securities reported no remaining Enzymotec Ltd position as of Q2 2017 after selling out during the quarter.
  • Gagnon Securities sold 377,302 Enzymotec Ltd shares in Q2 2017, an estimated $234K.
  • Gagnon Securities first reported a position in Enzymotec Ltd in Q2 2016 and held it in 4 quarters.
  • Gagnon Securities's Enzymotec Ltd position peaked at $2.02M in Q2 2016.
  • 21 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q2 2017.

Based on Gagnon Securities's 13F filing for Q2 2017, filed 20 Jul 2017.